Statements (27)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
1989
|
| gptkbp:ATCCode |
N04BD01
|
| gptkbp:brand |
gptkb:selegiline
|
| gptkbp:CASNumber |
gptkb:14611-51-9
|
| gptkbp:chemicalFormula |
C13H17N
|
| gptkbp:contraindication |
concomitant use with SSRIs
concomitant use with meperidine concomitant use with tricyclic antidepressants |
| gptkbp:discoveredBy |
gptkb:Zoltan_Ecseri
|
| gptkbp:drugClass |
monoamine oxidase inhibitor
|
| gptkbp:eliminationHalfLife |
10 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
Eldepryl
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
Somerset Pharmaceuticals
|
| gptkbp:metabolism |
gptkb:L-amphetamine
gptkb:L-methamphetamine |
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness insomnia |
| gptkbp:usedFor |
gptkb:Parkinson's_disease
gptkb:major_depressive_disorder |
| gptkbp:bfsParent |
gptkb:Selegiline
gptkb:selegiline |
| gptkbp:bfsLayer |
7
|